Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
EDBI

EDBI

EDBI is a premier Asian investor with headquarters in Singapore.

Investing since 1991, EDBI is a Singapore-based global investor in select high growth technology sectors ranging from Information & Communication Technology (ICT), Emerging Technology (ET), Healthcare (HC) and other strategic industries. As a value-creating investor, EDBI assists companies to achieve their goals by leveraging their network, resources, and capital, EDBI supports companies seeking to grow in Asia and globally through Singapore.

In their investments, EDBI looks for experienced management teams with differentiated products with established product market fits or which overcomes market inefficiencies, a commercially attractive business model and a vision to compete globally.

Investment

EDBI's investments include SWAT, M-DAQ, Cityneon, Nuvation Bio, Structo, Inari, Biofourmis, ShopBack, CXA Group, Moka, Ambiq Micro and OakNorth.

Their exited investments include Livongo, LogRhythm, Moderna Therapeutics, Smaato, Knewton, Hedvig, Revance Therapeutics, Mblox, goBalto, Appcelerator, Fluidigm, Declara and Addex Therapeutics.

Timeline

Invested in

Patents

Funding Rounds Participated In

Further Resources

Title
Author
Link
Type
Date

News

Title
Author
Date
Publisher
Description
Ajay Chhibber
July 21, 2021
@bsindia
Business index rankings have become a substitute for addressing the fundamental constraints faced by entrepreneurs
Hummingbird Bioscience
May 18, 2021
www.prnewswire.com:443
/PRNewswire/ -- Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets to...
AvePoint, Inc.
March 1, 2021
www.prnewswire.com:443
/PRNewswire/ -- AvePoint, Inc., one of the largest Microsoft 365 data management solutions providers, announced today the global launch of AvePoint EduTech....
Catherine Shu
September 3, 2020
TechCrunch
Biofourmis, which combines AI-based data analytics and biosensors to monitor the progress of medical treatments, has raised funding from one of the world's most high-profile investors. The digital therapeutics company, which launched in Singapore and is now headquartered in Boston, announced today it closed a $100 million Series C led by SoftBank Vision Fund 2, [...]

References

Golden logo
By using this site, you agree to our Terms & Conditions.